Transcription of Docetaxel + CDDP + 5-FU (DCF)化学療法を受けた
{{id}} {{{paragraph}}}
JFMC - -C5 EPOC2 study DCF III EPOC2 study Stage International Union Against Cancer TNM classification system, 7th edition 11 2 8 2017 1 2019 8 12 3 2017 1 2019 12 2016 11 7 2016 11 29 2016 12 19 1 0. DCF StageII III DCF Docetaxel , Cisplatin, Fluorouracil + Docetaxel (DOC) 35mg/m2 day1, day15 Cisplatin( cddp ) 40mg/m2 day1, day15 Fluorouracil (5-FU) 400mg/m2 day1-5, day15-19 4 2 2 600kcal /day 8 2 600kcal /day 1 2 1 Docetaxel , Cisplatin, Fluorouracil Docetaxel (DOC) 35mg/m2 day1, day15 Cisplatin( cddp ) 40mg/m2 day1, day15 Fluorouracil (5-FU) 400mg/m2 day1-5, day15-19 4 2 A DCF + B DCF 70 / / day1 3 1 2 Cisplatin( cddp )+Fluorouracil(5-FU) Docetaxel (DOC)
2 0.2. 目的 食道癌に対する現在の標準化学療法であるCisplatin(CDDP)+Fluorouracil(5-FU)併用療 法にDocetaxel(DOC)を加えたBiweekly-DCF 療法で起こる口腔粘膜炎に対し、成分栄養
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}